Originally published Wednesday, June 4, 2008 at 12:00 AM
Seattle Genetics says lymphoma drug showed strong results
An experimental drug to treat Hodgkin lymphoma and similar cancers showed a strong patient response in early clinical trials...
Seattle Times business reporter
An experimental drug to treat Hodgkin lymphoma and similar cancers showed a strong patient response in early clinical trials, Seattle Genetics said Tuesday.
The Bothell company said that of 38 patients being evaluated, five saw their tumors disappear and seven showed significant reductions. The disease remained stable in 15 patients, while it progressed in 11 patients.
In total, about 81 percent of the observed patients saw at least some reduction in their tumors, the company said.
Seattle Genetics has begun talking with the U.S. Food and Drug Administration about an accelerated process to approve the drug for patients with relapsed or refractory Hodgkin lymphoma, which currently have no treatment, said Chief Executive Clay Siegall. The FDA can speed the approval of therapies treating unmet medical needs.
The company hopes to have a plan for two pivotal clinical studies by the end of the year for the product, known as SGN-35. If all conditions are met, it could get a regulatory nod as early as 18 months from the beginning of the studies, Siegall said.
"We think it's likely that this will be our first product to be approved," Siegall said.
The therapy, still in early experimentation in humans, could overtake Seattle Genetics oncology compounds SGN-33 and SGN-40, which are in more advanced clinical trials.
SGN-40, a treatment for slow-growing non-Hodgkin lymphoma and other ailments, brought Seattle Genetics a lucrative partnership with biotech giant Genentech in early 2007. Currently the company has seven products in its research pipeline.
Seattle Genetics' data for the drug, presented at the American Society of Clinical Oncology annual meeting in Chicago, is "fabulous," said David Miller, an analyst with Seattle-based Biotech Stock Research. "I'd be surprised if this doesn't move into a pivotal trial."
SGN-35 has gotten a lot of attention from potential partners, said Siegall. The company, which had more than $167 million in cash and investments as of March 31, is mostly interested in deals where a partner would take over the launch of the product outside of the United States, he said.
Shares of Seattle Genetics, the largest independent biotech company in the Seattle area by market capitalization, traded down 4.89 percent Tuesday to $8.56.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2008 The Seattle Times Company
UPDATE - 01:37 PM
Cell Therapeutics stock resumes trading after week-long halt

PNW Magazine | Easy As Pie
A little friendly competition between professional pie-baker Kate McDermott and The Seatttle Times' Kathleen Triesch Saul is handled with great taste.
general classifieds
Garage & estate salesFurniture & home furnishings
Sporting goods
just listed
42" Hitachi Plasma 1080i - $500
8 Drawer Dresser with Attached Mirror - $200
8 seat pecon formal dining table and china hutch - $1500
More listings
POST A FREE LISTING
shopping
events for Monday, Nov. 23
- Contractors equipment and vehicle auction
- $100 Holiday Blitz at Ella Mon
- Furnishments Thanksgiving Weekend Sale
- Black Friday Sale at Merge
editors' picks
More shopping guides- 'The Road' takes Viggo Mortensen to Mount St. Helens and Astoria, Ore.
- Tugboat sinks at Seattle waterfront pier
- Illegal workers quietly let go
- Child-support error costs nearly $21,000
- Vikings easily beat the Seahawks
- Craigslist adoption ad: A plea by young mother-to-be? A scam?
- Chase shrugs off loss of CD investors
- Woman stabbed by stranger in North Seattle
- Snow piles up on Cascade slopes
- Denny Triangle gains skyline, but tenants slow to come
- Illegal workers quietly let go
393 - Climate change speeds up since 1997 Kyoto accord
212 - Metro won't cut bus service after all
159 - New Husky recruit: Enes Kanter
101 - Tattoos at Mill Creek Church pierce skin, soul
85 - Middleton says Huskies "plan on scoring at least 50 points'' Saturday
82 - Jerry Brewer: Seahawks can't lean on the Hutch Crutch now
75 - Seattle woman charged with knife attack on boyfriend's ex
71 - UW, WSU once again meet to see who's worse
68 - Bellevue residents blast new bikini espresso stand
64
- Sprouts, raw fish on attorney's 'do not eat' list
- Tattoos at Mill Creek church pierce skin, soul
- Food-safety lawyer's wish: Put me out of business
- Illegal workers quietly let go
- Architects, chefs find 'kid' within to build Gingerbread Village
- Rediscovering Moab, 'the most beautiful place on Earth'
- It's possible to recover a life lost to hoarding
- Child-support error costs nearly $21,000
- 'The Road' takes Viggo Mortensen to Mount St. Helens and Astoria, Ore.
- Taste | The Great Pie Bake-off pits friends and fruit




